Full Name
George Caleb Michael
Caleb, M.
Caleb, M.G.
Main Affiliation


Results 1-7 of 7 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
1Jul-2006Cardiac inflammatory myofibroblastic tumor as a rare cause of aortic regurgitation: A case reportSu, J.W.; Caleb, M.G. ; Tan, R.S. ; Low, A.F.H. ; Lim, C.H.
22020Comparison of postoperative cognitive decline in patients undergoing conventional vs miniaturized cardiopulmonary bypass: A randomized, controlled trialYuhe, K.; Huey Chew, S. ; Ang, A. ; Ge Ng, R.R.; Boonkiangwong, N.; Liu, W. ; Hao Toh, A.H.; Caleb, M.G. ; Man Ho, R.C. ; Ti, Lian Kah 
32008Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary arteryWebb, G.D.; Oh, V.M.S. ; Soh, B.Y.; Taylor, E.A.; Lay, H.L. ; Yoke, P.C.; Ali, M.Y.; Bhatia, M. ; Moore, P.K. ; El, Oakley R. ; Chuen, N.L. ; Poo, S.W. ; Caleb, M.G. ; Salto-Tellez, M. ; Chan, E.S.Y.
42009Endovascular management of traumatic thoracic aortic transection.Asmat, A.; Tan, L. ; Caleb, M.G. ; Lee, C.N. ; Robless, P.A. 
52015Ethical dilemmas in adult ECMO: emerging conceptual challengesRAMANATHAN K.R. ; Cove M ; Caleb MG ; Teoh KL ; MacLaren G 
6May-2011Pericardiophrenic artery embolisation for control of massive haemoptysisBhasin, A.; Venkatesh, S.K. ; Caleb, M.G. 
72009Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)Lim, E.H. ; Chang, A.; Tan, P. ; Zhang, S.-L. ; Li, J.-L.; Yap, W.-S.; Ng, A.; Howe, T.-C.; Tan, B.-P.; Lee, Y.-S.; Wong, D.; Khoo, K.-L.; Seto, K.-Y.; Tan, L. ; Agasthian, T.; Koong, H.-N. ; Tam, J. ; Tan, C.; Caleb, M.